Surgaflex™
Clinically Proven
In a Prospective Clinical Case Series published in the October 2021 edition of WOUNDS journal, 22 diabetic patients undergoing various surgical procedures were evaluated.
Inclusion Criteria: Diabetic patients – a 13% historical SSI rate. The study’s primary objective was to decrease this rate to 6.5% by prophylactic treatment using Surgaflex™
Procedure: Surgical procedures included amputation, removal of exostosis, midfoot bone removal, Achilles’ tendon repair, bunionectomy, or an elevating osteotomy with primary closure of the wound. Patients were assessed on day 3 or 5 for SSI incidence and followed for 90 days.
Results: The per-protocol patient population (20/22) had a 0% SSI rate with healing times typical to the procedure (between 10 and 34 days). Two patients were not included in the analysis due to non-compliance.9
